Defective RNA ribose synthesis in fibroblasts from patients with thiamine-responsive megaloblastic anemia (TRMA)
Open Access
- 15 November 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (10) , 3556-3561
- https://doi.org/10.1182/blood-2003-05-1537
Abstract
Fibroblasts from patients with thiamine-responsive megaloblastic anemia (TRMA) syndrome with diabetes and deafness undergo apoptotic cell death in the absence of supplemental thiamine in their cultures. The basis of megaloblastosis in these patients has not been determined. Here we use the stable [1,2-13C2]glucose isotope-based dynamic metabolic profiling technique to demonstrate that defective high-affinity thiamine transport primarily affects the synthesis of nucleic acid ribose via the nonoxidative branch of the pentose cycle. RNA ribose isolated from TRMA fibroblasts in thiamine-depleted cultures shows a time-dependent decrease in the fraction of ribose derived via transketolase, a thiamine-dependent enzyme in the pentose cycle. The fractional rate of de novo ribose synthesis from glucose is decreased several fold 2 to 4 days after removal of thiamine from the culture medium. No such metabolic changes are observed in wild-type fibroblasts or in TRMA mutant cells in thiamine-containing medium. Fluxes through glycolysis are similar in TRMA versus control fibroblasts in the pentose and TCA cycles. We conclude that reduced nucleic acid production through impaired transketolase catalysis is the underlying biochemical disturbance that likely induces cell cycle arrest or apoptosis in bone marrow cells and leads to the TRMA syndrome in patients with defective high-affinity thiamine transport. (Blood. 2003;102: 3556-3561)Keywords
This publication has 24 references indexed in Scilit:
- Stable Isotope-Based Dynamic Metabolic Profiling in Disease and HealthPublished by Springer Nature ,2003
- Imatinib and Chronic-Phase LeukemiasNew England Journal of Medicine, 2002
- Metabolic profiling of cell growth and death in cancer: applications in drug discoveryDrug Discovery Today, 2002
- Metabolic control analysis in drug discovery and diseaseNature Biotechnology, 2002
- Gleevec (STI571) Influences Metabolic Enzyme Activities and Glucose Carbon Flow toward Nucleic Acid and Fatty Acid Synthesis in Myeloid Tumor CellsJournal of Biological Chemistry, 2001
- The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporterNature Genetics, 1999
- Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblastsJournal of Clinical Investigation, 1999
- Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucoseAmerican Journal of Physiology-Endocrinology and Metabolism, 1998
- Pathways of carbohydrate metabolism and their physiological significanceJournal of Chemical Education, 1965
- Pathways of Carbohydrate Metabolism in Normal and Neoplastic CellsNew England Journal of Medicine, 1958